2142 — HBM Holdings Share News
0.000.00%
Last trade - 00:00- HK$9.03bn
- HK$6.91bn
- $157.98m
Brief: HBM Holdings Sees Profit Within Range Of RMB7.3 Mln To RMB22 Mln For Year
Brief: HBM Holdings Says NMPA Ind Clearance For Hbm9378/Skb378
Brief: HBM Says CEO & Chairman Purchased Total 400,000 Ordinary Shares Of Co
Brief: HBM Holdings Announces License Agreement With Windward Bio AG
Brief: Windward Bio Launches With $200 Million Series A Financing
Brief: Harbour Biomed Signs License Agreement With Windward Bio For HBM9378
Brief: HBM Holdings To Repurchase Shares In Open Market Up To Hk$40 MLN
Brief: Hbm Holdings Says Unit Entering T-Cell Engager Discovery Collaboration With Candid Therapeutics
Brief: HBM Announces Submission Of Investigational New Drug Application For Hbm9378/Skb378
Advisory: Alert incorrectly tagged to China's HBM Holdings Ltd withdrawn
Brief: Hbm Holdings Collaborates With Cullinan Therapeutics, Inc. For Hbm7008
Brief: HBM Holdings Sees HY Profit In Range Of $1 Mln To $1.5 Mln
Brief: HBM Holdings Re-Submits Biologics License Application For Batoclimab To NMPA
Brief: HBM Holdings Says Unit Entered License & Option Agreement With Astrazeneca
Brief: HBM Holdings Saus Unit And Boostimmune Entered Agreement
Brief: Harbour Biomed Announces IND Clearance For HBM9027 In The U.S.
Brief: HBM Holdings Says Granted Clearance Of Investigational New Drug From FDA In US
Brief: HBM Holdings Sees Profit Of Around US$18 Mln For FY 2023
HK-listed HBM jumps on forecasting first annual profit since debut